In a study of >20,000 individuals from Mayo Clinic and the Alzheimer's Disease Genetics Consortium (ADGC), we identified associations with both reduced AD risk and reduced brain MAPT levels with the H2 haplotype.14 This evidence concerns the gene MAPT and Alzheimer disease.